Fundz

XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of Units

PUBLIC · XRTXFeb 19, 2024

Amount Raised

$2.47 Million

Round Type

Seed

CalgaryBiotechnologyHealth CareTherapeuticsPharmaceuticalPharmaceutical Manufacturing

Description

XORTX Therapeutics Inc. has announced an initial closing of gross proceeds of $2,474,301 under a prospectus supplement and concurrent private placement for the offering of units. The company anticipates a second tranche closing under the same terms of the offering to occur on or about February 20, 2024.

Quick answer

XORTX Therapeutics raised $2.47 Million in a Seed round, dated February 19, 2024. XORTX Therapeutics is based in Calgary, Alberta, Canada.

How much did XORTX Therapeutics raise?
XORTX Therapeutics raised $2.47 Million in a Seed round on February 19, 2024.
What does XORTX Therapeutics do?
XORTX Therapeutics Inc. is a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease.
Where is XORTX Therapeutics based and how big is it?
XORTX Therapeutics is based in Calgary, Alberta, Canada.
Who are the decision-makers at XORTX Therapeutics?
Fundz holds 1 contact at XORTX Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as XORTX Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • TORL BioTherapeutics raised $158M on April 4, 2024.
  • Algernon Pharmaceuticals raised $13K (Pre-Seed) on April 3, 2024.
  • Neurosterix raised $63M (Series A) on April 3, 2024.
  • Azora Therapeutics, Inc. (DE) raised $288K (Seed) on March 6, 2024.
  • Crinetics Pharmaceuticals raised $350M on March 1, 2024.
  • Parabilis Medicines raised $145M (Series E) on March 1, 2024.

Who to call at XORTX Therapeutics, and when

A new round usually means XORTX Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day XORTX Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at XORTX Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at XORTX Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

XORTX Therapeutics

Location

Calgary, Alberta, Canada

About

XORTX Therapeutics Inc. is a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. The company has two clinically advanced products in development with a dedication to improving the quality of life and future health of patients with kidney disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment XORTX Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for XORTX Therapeutics's next move

See what Strategic adds

XORTX Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.